Clinical Trials on Immune-mediated Thrombocytopenic Purpura in Brazil
Total 6 results
-
Novartis PharmaceuticalsCompletedImmune Thrombocytopenic Purpura (ITP)Spain, Italy, Greece, Switzerland, United Kingdom, France, Turkey, Russian Federation, Brazil, Austria, Mexico, Oman, Chile, Japan, United States
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedHelicobacter Pylori Infection | Immune Thrombocytopenic PurpuraBrazil
-
AmgenCompletedImmune ThrombocytopeniaUnited States, Canada, Belgium, Czechia, Mexico, Turkey, Australia, Spain, France, Israel, Hungary, South Africa, Poland, Russian Federation, United Kingdom, Brazil, Switzerland
-
Principia Biopharma, a Sanofi CompanyRecruitingImmune ThrombocytopeniaUnited States, China, Argentina, Australia, Brazil, Canada, France, Hungary, Israel, Korea, Republic of, Mexico, Russian Federation, Singapore, Spain, Thailand, United Kingdom, Austria, Chile, Germany, Italy, Japan, Netherlands, Norway and more
-
Instituto Fernandes FigueiraCompletedSmoking Cessation | Nicotine Replacement Therapy | Brachial Flow Mediated DilatationBrazil
-
The Immunobiological Technology Institute (Bio-Manguinhos)...Oswaldo Cruz FoundationRecruitingGuillain-Barre Syndrome | Transverse Myelitis | Acute Disseminated Encephalomyelitis | Vaccine-induced Thrombotic Thrombocytopenia SyndromeBrazil